Advanced search
Publication Cover
Hematology Volume 25, 2020 - Issue 1
Submit an article Journal homepage
2,676
Views
12
CrossRef citations to date
0
Altmetric
Articles

The association between antinuclear antibody and response to rituximab treatment in adult patients with primary immune thrombocytopenia

Yan-ming Wanga Department of Hematology, Qilu Hospital, Shandong University, Jinan, People’s Republic of China;b Department of Hematology, Yantai Yuhuangding Hospital Affiliated to Qingdao University, Yantai, People’s Republic of ChinaView further author information
,
Ya-fei Yua Department of Hematology, Qilu Hospital, Shandong University, Jinan, People’s Republic of ChinaView further author information
,
Yu Liuc School of Chemistry and Pharmaceutical Engineering, Qilu University of Technology, Jinan, People’s Republic of ChinaView further author information
,
Shuang Liud Department of Hematology, Taian Central Hospital, Taian, People’s Republic of ChinaView further author information
,
Ming Houa Department of Hematology, Qilu Hospital, Shandong University, Jinan, People’s Republic of China;e Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Jinan, People’s Republic of ChinaView further author information
&
Xin-guang Liua Department of Hematology, Qilu Hospital, Shandong University, Jinan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 139-144 | Published online: 13 Mar 2020

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Junnan Su, Meihong Xu, Zhigao Dong, Qingqing Wang, Lili Ma, Pingping Xiao & Xuyan Chen. (2023) Efficacy and safety of azathioprine plus prednisone versus prednisone alone as first-line treatment for antinuclear antibody-positive immune thrombocytopenia: a retrospective cohort study. Hematology 28:1.
Read now
Yan-Qiu Hou, Yan Wang, Chang-Xun Liu, Shu-Xia Li, Ya-Lan Peng, Wang Dong-Dong & Ru-La Sa. (2022) The association between platelet glycoprotein-specific antibodies and response to short-term high-dose dexamethasone with prednisone maintenance treatment in adult patients with primary immune thrombocytopenia. Annals of Medicine 54:1, pages 132-137.
Read now

Articles from other publishers (10)

Guillaume Moulis & Lamya Garabet. (2023) Markers of refractory primary immune thrombocytopenia. British Journal of Haematology 203:1, pages 112-118.
Crossref
Guillaume Moulis, Nathalie Aladjidi & Bertrand Godeau. (2023) Clinical significance of antinuclear antibodies in primary immune thrombocytopenia. British Journal of Haematology 203:1, pages 131-135.
Crossref
Jing Liu, Yuelun Zhang, Zhuo Li, Ji Li, Lejia Zhang, Yuqing Song, Zichao Lyu, Changyan Wang, Lijuan Gou, Meiying Quan, Juan Xiao & Hongmei Song. (2023) The effect of antinuclear antibody titre and its variation on outcomes in children with primary immune thrombocytopenia. British Journal of Haematology 202:2, pages 412-421.
Crossref
Alessandro Allegra, Nicola Cicero, Giuseppe Mirabile, Concetto Mario Giorgianni & Sebastiano Gangemi. (2023) Novel Biomarkers for Diagnosis and Monitoring of Immune Thrombocytopenia. International Journal of Molecular Sciences 24:5, pages 4438.
Crossref
Xin-guang Liu, Yu Hou & Ming Hou. (2023) How we treat primary immune thrombocytopenia in adults. Journal of Hematology & Oncology 16:1.
Crossref
L. P. Ananyeva, L. A. Garzanova, O. A. Koneva, M. N. Starovoytova, O. V. Desinova, O. B. Ovsyannikova, R. U. Shayakhmetova, M. V. Cherkasova, A. P. Aleksankin & E. L. Nasonov. (2022) Anti-topoisomerase 1 antibody level changes after B сell depletion therapy in systemic sclerosis. Rheumatology Science and Practice 60:1, pages 57-63.
Crossref
Mehmet Baysal, Volkan Baş, Elif Ümit, Hakkı Onur Kırkızlar & Ahmet Muzaffer Demir. (2022) Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?. Turkish Journal of Hematology 39:1, pages 38-42.
Crossref
Kundan Mishra, Suman Kumar, Aditya Jandial, Kamal Kant Sahu, Rajeev Sandal, Ankur Ahuja, Sanjeev Khera, Yanamandra Uday, Rajiv Kumar, Rajan Kapoor, Tarun Verma, Sanjeevan Sharma, Jasjit Singh, Satyaranjan Das, Tathagat Chatterjee, Ajay Sharma & Velu Nair. (2021) Real-world Experience of Rituximab in Immune Thrombocytopenia. Indian Journal of Hematology and Blood Transfusion 37:3, pages 404-413.
Crossref
Zeineb Zian, S.P. Déo-Gracias Berry, Nazila Bahmaie, Dana Ghotbi, Ali Kashif, Manisha Madkaikar, Umair Ahmed Bargir, Hamisu Abdullahi, Haroon Khan & Gholamreza Azizi. (2021) The clinical efficacy of Rituximab administration in autoimmunity disorders, primary immunodeficiency diseases and malignancies. International Immunopharmacology 95, pages 107565.
Crossref
Anurag Singh, Günalp Uzun & Tamam Bakchoul. (2021) Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management. Journal of Clinical Medicine 10:4, pages 789.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.